Maridas D, Gamer L, Moore E, Doedens A, Yu Y, Ionescu A, et al. Loss of Vlk in Prx1+ Cells Delays the Initial Steps of Endochondral Bone Formation and Fracture Repair in the Limb. J Bone Miner Res. 2022;37:764-775 pubmed publisher

Wei R, Wong J, Lyu P, Xi X, Tong O, Zhang S, et al. In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer. J Cell Mol Med. 2018;22:4097-4105 pubmed publisher

Wong J, Wei R, Lyu P, Tong O, Zhang S, Wen Q, et al. Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer. Int J Biol Sci. 2017;13:1373-1386 pubmed publisher

Yushi Q, Li Z, von Roemeling C, Doeppler H, Marlow L, Kim B, et al. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. Oncotarget. 2016;7:32156-71 pubmed publisher

Nakamura T, Shinriki S, Jono H, Ueda M, Nagata M, Guo J, et al. Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma. FEBS Lett. 2015;589:231-9 pubmed publisher